These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 20828790)

  • 1. Efficacy and safety of naproxcinod in patients with osteoarthritis of the knee: a 53-week prospective randomized multicenter study.
    Schnitzer TJ; Hochberg MC; Marrero CE; Duquesroix B; Frayssinet H; Beekman M
    Semin Arthritis Rheum; 2011 Feb; 40(4):285-97. PubMed ID: 20828790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
    Karlsson J; Pivodic A; Aguirre D; Schnitzer TJ
    J Rheumatol; 2009 Jun; 36(6):1290-7. PubMed ID: 19411388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.
    Schnitzer TJ; Kivitz A; Frayssinet H; Duquesroix B
    Osteoarthritis Cartilage; 2010 May; 18(5):629-39. PubMed ID: 20202489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and Ibuprofen in the treatment of osteoarthritis of the knee.
    Schiff M; Minic M
    J Rheumatol; 2004 Jul; 31(7):1373-83. PubMed ID: 15229960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: a randomized, double-blind, parallel-group, multicenter study.
    Baerwald C; Verdecchia P; Duquesroix B; Frayssinet H; Ferreira T
    Arthritis Rheum; 2010 Dec; 62(12):3635-44. PubMed ID: 20722026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of naproxcinod on blood pressure in patients with osteoarthritis.
    White WB; Schnitzer TJ; Bakris GL; Frayssinet H; Duquesroix B; Weber M
    Am J Cardiol; 2011 May; 107(9):1338-45. PubMed ID: 21371681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study.
    Levy RM; Saikovsky R; Shmidt E; Khokhlov A; Burnett BP
    Nutr Res; 2009 May; 29(5):298-304. PubMed ID: 19555810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
    Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
    Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of flavocoxid compared with naproxen in subjects with osteoarthritis of the knee- a subset analysis.
    Levy R; Khokhlov A; Kopenkin S; Bart B; Ermolova T; Kantemirova R; Mazurov V; Bell M; Caldron P; Pillai L; Burnett B
    Adv Ther; 2010 Dec; 27(12):953-62. PubMed ID: 20972845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.
    Altman RD; Moskowitz R
    J Rheumatol; 1998 Nov; 25(11):2203-12. PubMed ID: 9818665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of the OARSI-OMERACT osteoarthritis pain and function measures.
    Bond M; Davis A; Lohmander S; Hawker G
    Osteoarthritis Cartilage; 2012 Jun; 20(6):541-7. PubMed ID: 22425883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double blind, randomized, placebo controlled study to evaluate the efficacy of erythromycin in patients with knee effusion due to osteoarthritis.
    Sadreddini S; Noshad H; Molaeefard M; Moloudi R; Ardalan MR; Ghojazadeh M
    Int J Rheum Dis; 2009 Apr; 12(1):44-51. PubMed ID: 20374316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis.
    White WB; Schnitzer TJ; Fleming R; Duquesroix B; Beekman M
    Am J Cardiol; 2009 Sep; 104(6):840-5. PubMed ID: 19733721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of etodolac-paracetamol fixed dose combination in patients with knee osteoarthritis flare-up: a randomized, double-blind comparative evaluation.
    Pareek A; Chandurkar N; Ambade R; Chandanwale A; Bartakke G
    Clin J Pain; 2010 Sep; 26(7):561-6. PubMed ID: 20639739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee.
    Niethard FU; Gold MS; Solomon GS; Liu JM; Unkauf M; Albrecht HH; Elkik F
    J Rheumatol; 2005 Dec; 32(12):2384-92. PubMed ID: 16331769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
    Kivitz A; Eisen G; Zhao WW; Bevirt T; Recker DP
    J Fam Pract; 2002 Jun; 51(6):530-7. PubMed ID: 12100776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis.
    Lohmander LS; McKeith D; Svensson O; Malmenäs M; Bolin L; Kalla A; Genti G; Szechinski J; Ramos-Remus C;
    Ann Rheum Dis; 2005 Mar; 64(3):449-56. PubMed ID: 15345500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee.
    Levy RM; Khokhlov A; Kopenkin S; Bart B; Ermolova T; Kantemirova R; Mazurov V; Bell M; Caldron P; Pillai L; Burnett BP
    Adv Ther; 2010 Oct; 27(10):731-42. PubMed ID: 20845002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.